Diabetes mellitus is a common metabolic disorder that affects more than 190 million people worldwide.
Ocular complications secondary to type 2 diabetes mellitus are a well-known cause of diabetic keratopathy. 5) Diabetic keratopathy is an entity that includes slow healing or loose adhesion of the corneal epithelium after wounding in diabetic patients. Histologically, it involves a thickening of the corneal epithelial basement membrane and morphologic changes in the corneal epithelium and endothelium. [6] [7] [8] [9] [10] [11] Clinically, the damage to the corneal epithelium during vitreous surgery and retinal photocoagulation sometimes induces vision-threatening corneal complications, such as persistent epithelial defects in diabetic patients. 12) It has been reported that such diabetic keratopathy is experienced by 50% or more of diabetic patients. 13) The corneal wound repair process involves cell adhesion, migration, proliferation, matrix deposition and tissue remodeling. 14) Many of these biological processes are mediated by growth factors, cytokines and other mediators released in injured tissues or cells. 15) These growth factors have been recognized as important mediators of proper wound repair, 16) and treatment with growth factors such as platelet-derived growth factor-BB, and recombinant human epidermal growth factor has been shown to be beneficial for patients with chronic pressure ulcers or non-healing diabetic ulcers. [17] [18] [19] [20] However, for reasons of effectiveness, safety and stable supply, a potent wound-healing agent for human corneal wounds has not yet been introduced, and the development of effective and safe corneal wound-healing drugs is highly anticipated.
Proteins such as fibroin and sericin are the main constituents of silk, with fibroin contributing 70 to 80% and sericin 20 to 30% of the total cocoon weight. 21 ) When cocoons or raw silk are used for textiles, the sericin is mostly removed from the cocoon and disposed of unused. However, sericin has recently been investigated for its activities in biotechnological fields. 22, 23) We reported that sericin instillation has a potent effect in promoting wound healing and wound-size reduction in rats. 24) Therefore, it is possible that sericin may be applied as eye drops for corneal wound repair in diabetic patients. In this study, we investigated the enhancing effects of sericin on corneal wound healing in the debrided corneal epithelium of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model for human type 2 diabetes.
MATERIALS AND METHODS

Animals and Reagents
Male Long-Evans Tokushima Otsuka (LETO) rats as normal controls and OLETF rats aged 38 weeks were used in this study. The LETO and OLETF rats were obtained from the Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan), housed under standard conditions (12 h/d fluorescent light (07:00-19:00), 25°C room temperature) and allowed free access to a commercial diet (CE-2, Clea Japan Inc., Tokyo, Japan) and water. All procedures were performed in accordance with the Kinki University School of Pharmacy Committee for the Care and Use of Laboratory Animals and the Association for Research in Vision and Ophthalmology resolution on the use of animals in research.
Pure Sericin TM (30 kDa) was obtained from Seiren Co., Ltd. (Fukui, Japan). All other chemicals used were of the highest purity commercially available.
Measurement of Blood Parameters for Diabetes Mellitus Blood was drawn from a tail vein of each rat at 9:00 a.m., and the plasma levels of glucose, triglycerides, and cholesterol were measured. Plasma glucose and triglycerides were determined by an Accutrend GCT (Roche Diagnostics, Mannheim, Germany). Plasma total cholesterol and highdensity lipoprotein (HDL)-cholesterol were measured by the cholesterol oxidase method and the phosphotungstate-magnesium salt method using a Cholesterol E-Test Kit (Wako, Osaka, Japan) and HDL-Cholesterol E-Test Kit (Wako, Osaka, Japan), respectively. The plasma low-density lipoprotein (LDL)-cholesterol level was calculated by Eq. 1:
Insulin levels were measured using an ELISA Insulin Kit according to the manufacturer's instructions (Morinaga Institute of Biological Science Inc., Kanagawa, Japan). Briefly, monoclonal antibodies specific for rat insulin were precoated onto microplates, standards and samples were pipetted into the wells, and the microplates were incubated at 4°C for 2 h. After washing to remove unbound materials, rat insulin antibodies were added to the wells at room temperature for 30 min. After washing, the substrates were added. The enzyme reactions yielded blue products that turned yellow when the stop solutions were added. The absorbance was measured with a microplate reader (BIO-RAD, California, U.S.A.) at 450 nm.
Instillation of Sericin Solutions in LETO and OLETF Rats The sericin solutions used in this study were prepared by adding Pure Sericin TM to saline (pH 6.5-7.5) on the day of experiment. Fifty microliters of saline or sericin solution were instilled into the eyes of rats five times a day (9:00, 12:00, 15:00, 18:00, 21:00) after corneal abrasion. The eyes were kept open for about 1 min after instillation to prevent the sericin from being washed out.
Image Analysis of Corneal Wound Healing in LETO and OLETF Rats The debridement of corneal epithelium in LETO and OLETF rat were performed as described previously. 24) LETO and OLETF rats were anesthetized with pentobarbital (30 mg/kg, i.p.), and a 3.5-mm-diameter circle was outlined in the center of the cornea with a disposable dermatological skin punch (BIOPSY PUNCH, Kai Industries Co., Ltd, Gifu, Japan). The encircled corneal epithelium was removed with a BD Micro-Sharp TM (blade 3.5 mm, 30°, Becton Dickinson, Fukushima, Japan). The area of removed corneal epithelium were followings: non-treated LETO rat, 9.73Ϯ 0.19; saline-instilled LETO rat, 9.81Ϯ0.56; 1% sericin-instilled LETO rat, 9.74Ϯ0.43; 5% sericin-instilled LETO rat, 9.90Ϯ0.83; 10% sericin-instilled LETO rat, 9.72Ϯ0.79; nontreated OLETF rat, 9.62Ϯ0.41; saline-instilled OLETF rat, 9.57Ϯ0.71; 1% sericin-instilled OLETF rat, 9.85Ϯ0.60; 5% sericin-instilled OLETF rat, 9.38Ϯ0.36; 10% sericin-instilled OLETF rat, 9.73Ϯ0.30 (mm 2 , meansϮS.E. of 3-5 independent rat corneas). The wound produced by the removal of corneal epithelium in 38-week-old LETO and OLETF rats was washed with a solution containing 1% fluorescein (Alcon, Tokyo, Japan) and 0.4% Benoxil (Santen Pharmaceutical Co., Ltd., Osaka, Japan). 24) Changes in the corneal wounds were monitored using a TRC-50X (Topcon, Tokyo, Japan) equipped with a digital camera (EOS Kiss Digital N, Canon Inc., Tokyo, Japan), 24) and analyzed with image J.
25)
The amount of corneal wound healing (%) was calculated by Eq. 2:
corneal wound healing (%) ϭ(wound area 0 h Ϫwound area 12-72 h )/wound area 0 h ϫ100
The rate of corneal wound healing is represented by the corneal wound healing rate constant (k H , h
Ϫ1
). The values of k H over the period 0-72 h after corneal epithelial abrasion were calculated from the following Eq. 3:
where t is time (0-72 h) after corneal abrasion, and H ∞ and H t are the percentages of corneal wound healing (%) at time ∞ and t, respectively. Statistical Analysis All data are expressed as the meansϮstandard errors (S.E.). Unpaired Student's t-test was used to evaluate statistical differences, and multiple groups were evaluated by one-way analysis of variance followed by Dunnett's multiple comparison. p values less than 0.05 were considered significant. The number of experiments performed in duplicate is given in the table and figure legends. Table 1 shows body weight and the plasma levels of plasma glucose, triglycerides, cholesterol and insulin in 38-week-old LETO and OLETF rats. The body weights of the OLETF rats were approximately 1.3-fold those of LETO rats. The plasma glucose and triglycerides, total cholesterol and LDL-cholesterol levels of the OLETF rats was significantly higher than that of the LETO rats. On the other hand, plasma HDL-cholesterol levels did not differ between the 38-weekold LETO and OLETF rats. The plasma insulin levels in OLETF rats were also significantly higher than in LETO rats, and a close relationship was observed between plasma insulin and glucose levels in OLETF rat (yϭϪ51xϩ335,
RESULTS
Body Weight and Plasma Levels of Glucose, Triglycerides, Cholesterol and Insulin in LETO and OLETF Rats
RϭϪ0.9094, nϭ4).
Rate of Corneal Wound Healing in LETO and OLETF Rats Figure 1 shows images obtained after corneal epithelial abrasion (A) and during corneal wound healing (B) in 38-week-old LETO and OLETF rat corneas. The degree of corneal wound healing was similar between LETO and OLETF rats until 12 h after corneal epithelial abrasion. The corneal wounds in LETO rats 48 h after corneal epithelial abrasion had almost healed entirely. On the other hand, corneal wound healing in OLETF rats was slower than in LETO rats, and the corneal wounds were healed by 72 h after corneal epithelial abrasion. In addition, a close relationship was observed between the corneal wound healing rate constant (k H ) and plasma glucose levels (yϭϪ17930xϩ603, RϭϪ0.8114, nϭ4). Figure 2 shows images of LETO (A) and OLETF (B) rats after corneal epithelial abrasion. Figure 3 shows corneal the wound healing levels in LETO (A) and OLETF (B) rat eyes instilled with 1, 5 and 10% solutions of sericin. The corneal wounds of OLETF rats instilled with saline were approximately 30% healed at 12 h after abrasion, and approximately 40% after 24 h. The corneal wounds of rat eyes instilled with saline were almost entirely healed 72 h after corneal epithelial abrasion. On the other hand, the corneal healing rates in LETO and OLETF rat eyes instilled with sericin solutions were faster than in the case of saline instillation, and the rate constants increased with increasing sericin concentration ( Table 2 ). The corneal wounds of OLETF rat eyes instilled with 10% sericin solution were approximately 45% healed at 12 h after corneal epithelial abrasion, and the wounds showed almost complete healing at 48 h after abrasion. The corneal healing rate constant of rat eyes instilled with 10% sericin solution was approximate 2.5-fold that of OLETF rat eyes instilled with saline. No differences of corneal healing rate constants were observed between LETO and OLETF rats eyes instilled with 5 and 10% sericin solutions (Table 2) .
Effect of the Instillation of Sericin Solutions on Corneal Wound Healing in LETO and OLETF Rats
DISCUSSION
Ocular complications secondary to type 2 diabetes are a well-known cause of diabetic keratopathy 5) ; however, for reasons of effectiveness, safety and stable supply, a potent corneal wound-healing agent for human corneal wounds has not yet been introduced. We previously reported that the instillation of sericin has a potent effect in promoting wound healing and wound-size reduction in rats. 24) Therefore, it is possible that sericin may be applied as eye drops for corneal wound repair. In this study, we investigated the enhancing effects of sericin on corneal wound healing in the debrided corneal epithelium of OLETF rats, a model for human type 2 diabetes.
In the development of corneal wound-healing drugs against type 2 diabetic mellitus, the selection of the experimental animal is very important. The OLETF rat is an established model of human type 2 diabetes. 26) Nearly 100% of male OLETF rats develop a diabetic syndrome by 25 weeks of age, and hyperglycemia and hyperinsulinemia are exhibited in the early phases of the disease as a result of islet cell hyperplasia and peripheral insulin resistance. [27] [28] [29] [30] With continued aging, the rats eventually develop hypoinsulinemia as a result of the deterioration of islet beta cells. 28, 30) These changes are similar to those in GK rats, which are used as a model animal for type 2 diabetic keratopathy. 31) However, while OLETF rats develop type 2 diabetic mellitus via a metabolic syndrome, GK rats develop type 2 diabetic mellitus without metabolic syndrome. Therefore, the changes in the biological characteristics of OLETF rats show an obvious correspondence to those that take place in human type 2 diabetes mellitus, indicating that OLETF rats may provide a better model than GK rats for studies to clarify the effects of corneal wound-healing drugs for type 2 diabetic mellitus.
In this study, the body weights of OLETF rats were approximately 1.3-fold higher than the LETO rats used as normal controls. Blood parameters for diabetes mellitus (glucose, triglycerides, total and LDL-cholesterol levels) in 38-week-old OLETF rats were significantly higher than in 38-week-old LETO rats. In addition, the insulin level in 38-week-old OLETF rats was also higher than in LETO rats, and a close relationship was observed between the plasma glucose and insulin levels (yϭϪ51xϩ335, RϭϪ0.9094). These results show that 38-week-old OLETF rats have insulin resistance and hyperinsulinemia. Hirashima et al. reported atrophy or the disappearance of beta cells in OLETF rats older than 60 weeks of age, and found that plasma insulin levels were lower than in LETO rats. 32, 33) Therefore, 38-week-old OLETF rats, which show insulin resistance and hyperinsulinemia, were used to compare the rates of corneal wound healing in this study.
It is important that injuries to the cornea be repaired rapidly in order to re-establish function. In general, it is known that epithelial cells from the corneal surface migrate and eventually cover the wound surface. This is followed by cell proliferation to rebuild the tissues, after which tissue remodeling leads to the restoration of the stratified epithelium. [34] [35] [36] [37] [38] [39] [40] The early stages of epithelial wound closure rely predominately on cell migration rather than cell proliferation; cell proliferation starts approximately 12-24 h after corneal epithelial injury. After that, tissue remodeling to restore the stratified epithelium occurs. 41, 42) The corneal wounds of LETO rats 48 h after corneal epithelial abrasion showed almost complete healing, while the corneal wounds of OLETF rats were repaired more slowly, with wound healing by 72 h after corneal epithelial abrasion. On the other hand, the rate of corneal wound healing in OLETF rats is similar to that in LETO rats up until 12 h after corneal epithelial abrasion. Therefore, the data suggest that cell movement, which is the main wound healing process up to 12 h after corneal epithelial abrasion, is unimpaired in OLETF rats, but rather a deficit in cell proliferation is responsible for the delay in corneal wound healing in this model.
It is important to observe the mechanisms underlying the delay in corneal wound healing in type 2 diabetic mellitus. In diabetes, the levels of glucose in the cornea and tears are increased. Glucose levels in the corneal epithelium have been reported to be 6 fold higher (1.8 to 12.2 mmol/g dry wet.) in diabetic patients than in normal controls, 43) and large increases in the glucose content of tears (range 2.16-9.55 mg/dl and 14.69-27.02 mg/dl for normal and diabetic patients, respectively) have also been reported. [44] [45] [46] March et al. reported that the glucose content of tears is approximately 10% the plasma glucose level, and that the glucose content of tears follows changes in plasma glucose levels. 47) High glucose levels suppress the proliferation of human corneal epithelial cells. 48) In addition, it has been reported that the instillation of insulin normalizes the delay in corneal wound healing in streptozotocin rats. 13) These previous reports show that the decrease in corneal wound healing in diabetic keratopathy is caused by a suppression of cell proliferation due to high glucose levels in tears. In this study, a close relationship was observed between the rate of corneal wound healing and plasma glucose levels (yϭϪ17930xϩ603, RϭϪ0.8114). This result supports the previous results for human diabetic keratopathy. 48) Therefore, OLETF rats may provide a useful model for studies to develop corneal woundhealing drugs for use in diabetic keratopathy resulting from type 2 diabetes mellitus.
We previously reported that the instillation of 10% sericin produces no observable neovascularization or inflammation. 24) In addition, the instillation of 10% sericin resulted in a significantly greater rate of corneal wound size reduction and healing than the instillation of 0.1% hyaluronic acid in Sprague-Dawley rat eyes, probably by increasing cell movement and proliferation. 24) In this study, the rates of corneal wound healing in both LETO and OLETF rat eyes were faster following the instillation of sericin than in the case of saline instillation, and the rate constant increased with increasing sericin concentration. The rates of corneal wound healing in OLETF rat eyes instilled with 5 or 10% sericin solution were similar to those of LETO rats treated similarly. In addition, the instillation of sericin did not affect glucose levels in the OLETF rats (saline instillation, 213.0Ϯ19.7 mg/dl; sericin instillation, 221.1Ϯ13.9 mg/dl; meansϮS.E. of 4 independent OLETF rats). The instillation of 5% or 10% sericin increased the amount of corneal wound healing in OLETF rats 12 h after corneal epithelial abrasion (Fig. 3) . Furthermore, we previously reported that sericin increases the adhesion and proliferation of human corneal epithelial cells in in vitro experiments. 24) Taken together, the instillation of sericin solution may counter the decreases in the rates of cell movement and proliferation, thus preventing the delay in corneal wound healing in OLETF rats.
In conclusion, the present study demonstrates that the rate of corneal wound healing in OLETF rats is slower than in LETO rats, probably due to the suppression of cell proliferation caused by high plasma glucose levels. The instillation of sericin solution has a potent effect in promoting wound healing and wound-size reduction in LETO and OLETF rats. We hypothesize that OLETF rats may provide a suitable animal model for diabetic keratopathy, and that sericin might provide an effective and safe drug to promote corneal wound healing in diabetic keratopathy. These findings provide information significant for designing further studies to develop potent drugs to improve the corneal wound-healing ability of diabetic patients.
